10 March 2025
|
2
min read
Genomics' Health Insights product was featured in The Times, highlighting its role in advancing preventative healthcare. Described as “the first genetic test capable of accurately predicting the risk of common diseases in an attempt to improve prevention,” the article notes that Bupa will be the first UK provider to offer the service following a pilot with 300 individuals.
This feature was originally published in The Times.
